|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.08.26 - 15:06
|
Bristol Myers Squibb Advances U.S. Manufacturing Investment with New $2.3 Billion Campus in Houston, Texas (Business Wire)
|
|
|
New State-of-the-Art Facility Will Create Nearly 500 Skilled Jobs and Accelerate the Delivery of Next-Generation Medicines
Investment Furthers BMS' $40 Billion Commitment to American Innovation, Manufacturing and Economic GrowthPRINCETON, N.J.--(BUSINESS WIRE)--$BMY #BMS--Bristol Myers Squibb (NYSE:BMY) today announced the selection of Houston, Texas, as the site for a new, state-of-the-art multi-modal manufacturing campus, representing an approximately $2.3 billion investment designed to accelerate the delivery of next-generation medicines to patients. The campus, at Generation Park in Houston, will create nearly 500 skilled jobs and is designed to grow in scale, capability and workforce for decades to come.
The selection of Houston marks a significant milestone in BMS' $40 billion commitment to invest in the United States over five years across research and development, technology and domestic manufacturing.
From day one, the Houston campus will be modular and multi-modal. Its modular design allows BM...
|
|
|
|
|
|
|
|
|
05.08.26 - 20:31
|
AstraZeneca Is Said to Have Explored Bristol Myers Merger (Bloomberg)
|
|
|
Bloomberg's Michelle Davis joins Dani Burger on "Bloomberg Deals." AstraZeneca has explored an acquisition of Bristol-Myers Squibb, according to people familiar with the matter, in a potential megadeal that would rank as the largest ever in pharma.
(Source: Bloomberg)...
|
|
|
05.08.26 - 20:06
|
Soriot should explain the curious case of AstraZeneca′s non-deal (The Guardian)
|
|
|
AstraZeneca's rumoured takeover of Bristol Myers Squibb already looked weird, and was met with a lack of enthusiasm by shareholdersAstraZeneca falls to third-largest UK company amid US merger talksHold the heartburn pills. It seems AstraZeneca is no longer contemplating a takeover of US rival Bristol Myers Squibb (BMS) to create a $400bn (£300bn) pharmaceutical colossus. On Monday, the UK firm's shares plunged 9% on the FT's report of preliminary talks. On Wednesday, Reuters said there are no ongoing discussions. Cue a mini-relief rally in AZ's share price.Neither company has seen fit to tell its shareholders what was happening, so it's impossible to know if the talks were a tentative 'what if?' corporate flirtation or something more substantial that has been killed, perhaps, by the lack of enthusiasm on the part of AZ's shareholders. Continue reading......
|
|
|
05.08.26 - 18:48
|
Börsenradio Schlussbericht, Mi., 05.08.2026: DAX bis 26.400 Punkte, dann endet die Rekordrallye - SpaceX stürzt ab (BRN)
|
|
|
Der DAX erreicht zunächst ein neues Rekordhoch von mehr als 26.400 Punkten, dreht am Nachmittag aber ins Minus und schließt 0,29 % tiefer bei 26.126,30 Punkten. Nach der schnellen Rallye nehmen Anleger Gewinne mit. Zugleich bleiben Zweifel an einer raschen Lösung im Iran-Krieg und an der vollständigen Öffnung der Straße von Hormus. SpaceX verliert nach den ersten Quartalszahlen als börsennotierter Konzern zeitweise 12 %. Der Umsatz liegt bei 7,8 Mrd. USD, der Nettoverlust bei 541 Mio. USD. Hinzu kommen hohe KI-Investitionen. Siemens Energy meldet Rekorde, Infineon erzielt 4,17 Mrd. Euro Umsatz und DHL steigert den operativen Gewinn um 30 % auf 1,9 Mrd. Euro. Bayer, Vonovia und Fresenius legen zu, während SpaceX mit seinen Mobilfunkplänen auch Telekom-Aktien unter Druck setzt. Weitere Themen sind neue Tankvorgaben für Airlines, der Führungswechsel bei McDonald's, dementierte Fusionsgerüchte bei AstraZeneca und Bristol Myers Squibb sowie der schwächere Pinterest-Ausblick. Börsenweisheit des T...
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
